GlassScriptPhysician profile
Linda D Jackson
NPI 1902906548
$4,657.02
in general payments reported to CMS, 2019-2025
41 companies · $575 in 2025
The $575 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,105 · 2022: $1,004 · 2023: $1,079 · 2024: $894 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $717.23 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $556.13 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $425.94 | 2021-2025 | |
| Amgen INC. | $402.54 | 2021-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $378.50 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $241.41 | 2022-2024 | |
| Lilly USA, LLC | $241.07 | 2021-2025 | Mounjaro, Amyvid, Zepbound |
| Astellas Pharma US INC | $161.82 | 2022-2025 | Veozah, Myrbetriq |
| E.R. Squibb & Sons, L.L.C. | $155.81 | 2021-2023 | Eliquis |
| Janssen Pharmaceuticals, INC | $142.91 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.53 | 2021-2022 | |
| Exact Sciences Corporation | $90.62 | 2023-2025 | Cologuard Collection Kit |
| Aimmune Therapeutics, INC. | $81.72 | 2024-2025 | Zenpep |
| Scilex Pharmaceuticals INC. | $76.41 | 2021-2024 | |
| Inspire Medical Systems, INC. | $71.59 | 2023 | Inspire |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.